Structural requirements for the binding of fatty acids to 5-lipoxygenase-activating protein
- 1 May 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 267 (3) , 275-280
- https://doi.org/10.1016/0922-4106(94)90151-1
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- 5‐Lipoxygenase‐activating protein stimulates the utilization of arachidonic acid by 5‐lipoxygenaseEuropean Journal of Biochemistry, 1993
- 5‐lipoxygenase‐activating protein is an arachidonate binding proteinFEBS Letters, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Reversible membrane association of neutrophil 5-lipoxygenase is accompanied by retention of activity and a change in substrate specificity.Journal of Biological Chemistry, 1992
- Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1992
- A novel arachidonic acid-selective cytosolic PLA2 contains a Ca2+-dependent translocation domain with homology to PKC and GAPCell, 1991
- Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesisNature, 1990
- Identification and isolation of a membrane protein necessary for leukotriene productionNature, 1990
- L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1989